Drawing for AGELESS BIOLOGICS

USPTO serial 99741321

AGELESS BIOLOGICS

Status 641Office Action
Filing date
Apr 2, 2026
Status date
Aug 31, 2026
Registration date
Examiner
NADEAU, MADELINE JEAN

Need help with AGELESS BIOLOGICS?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Deadline: November 30, 2026

Office Action issues

The examiner has identified that you need to disclaim descriptive wording, amend your service descriptions, satisfy multi-class requirements, pay an additional fee, and provide a valid domicile address.

Owner

  • Sovereign Grid Technologies

    Sheridan, WY, US

Goods and services

ClassDescriptionStatusFirst use
044Medical services in the field of biological multi-component peptide therapy; providing information in the field of biological multi-component peptide supplements and their medical applications; biological medical consultation services in the field of peptide-based treatments and therapies; healthcare services featuring the use of biological multi-component peptide and Distributorship services in the field of biological materialsACTIVE

Prosecution history

DateCodeEvent
Aug 31, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 31, 2026GNRTNON-FINAL ACTION E-MAILED
Aug 31, 2026CNRTNON-FINAL ACTION WRITTEN
Aug 12, 2026DOCKASSIGNED TO EXAMINER
Aug 10, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 2, 2026MAFRAPPLICATION FILING RECEIPT MAILED
Apr 2, 2026NWAPNEW APPLICATION ENTERED

Related guidance